Because cancer cells with flawed checkpoint proteins may be more vulnerable than normal cells to microtubule poisons [33], the cleavage and decrease of BUBR1 protein under the combinatory treatment with vinorelbine and YL-9 could further facilitate the cells into cell death. This evidence concerns the gene BUB1B and cancer.